- Home
- PMM vs NAUT Comparison
PMM vs NAUT Comparison
Compare PMM & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMM
- NAUT
- Stock Information
- Founded
- PMM 1989
- NAUT 2016
- Country
- PMM United States
- NAUT United States
- Employees
- PMM N/A
- NAUT N/A
- Industry
- PMM Investment Managers
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- PMM Finance
- NAUT Industrials
- Exchange
- PMM Nasdaq
- NAUT Nasdaq
- Market Cap
- PMM 265.3M
- NAUT 91.5M
- IPO Year
- PMM N/A
- NAUT N/A
- Fundamental
- Price
- PMM $5.99
- NAUT $0.80
- Analyst Decision
- PMM
- NAUT Strong Sell
- Analyst Count
- PMM 0
- NAUT 1
- Target Price
- PMM N/A
- NAUT $1.75
- AVG Volume (30 Days)
- PMM 118.3K
- NAUT 570.5K
- Earning Date
- PMM 01-01-0001
- NAUT 07-29-2025
- Dividend Yield
- PMM 4.68%
- NAUT N/A
- EPS Growth
- PMM N/A
- NAUT N/A
- EPS
- PMM 0.23
- NAUT N/A
- Revenue
- PMM N/A
- NAUT N/A
- Revenue This Year
- PMM N/A
- NAUT N/A
- Revenue Next Year
- PMM N/A
- NAUT N/A
- P/E Ratio
- PMM $26.52
- NAUT N/A
- Revenue Growth
- PMM N/A
- NAUT N/A
- 52 Week Low
- PMM $5.00
- NAUT $0.66
- 52 Week High
- PMM $6.42
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- PMM 57.44
- NAUT 55.25
- Support Level
- PMM $5.92
- NAUT $0.69
- Resistance Level
- PMM $6.04
- NAUT $0.85
- Average True Range (ATR)
- PMM 0.05
- NAUT 0.06
- MACD
- PMM 0.01
- NAUT 0.01
- Stochastic Oscillator
- PMM 72.22
- NAUT 70.59
About PMM Putnam Managed Municipal Income Trust
Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.